Survival Prediction After Neoadjuvant Chemoimmunotherapy and Esophagectomy for Esophageal Squamous Cell Carcinoma
N/A
The goal of this retrospective observational study is to develop and intern...
Status
Completed
Location
West China Hospital, Sichuan University
Start Date
2026-03-01
Trial ID
NCT07488624
Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05)
PHASE2
Neoadjuvant radiotherapy plus Tegafur, Oxaliplatin and Iparomlimab and Tuvo...
Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy
PHASE2
RATIONALE: Colony stimulating factors, such as sargramostim (GM-CSF), may s...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
SBRT Followed by Neoadjuvant Chemoimmunotherapy of Sindilizumab Plus Docetaxel and Cisplatin for Locoregionally Advanced Squamous Carcinoma of Oral Cavity and Oropharynx
PHASE2
In resectable locally advanced oral cavity cancer and oropharyngeal cancer,...